Skip to main content
SpringerLink
Log in

Movement Disorders in the Emergency

  • Chapter
  • First Online:
Emergencies in Neurology

  • 606 Accesses

Abstract

Movement disorders classically have an insidious onset and slow progression and are usually not associated with emergency situations. Infrequently, there do arise rapidly evolving movement disorders or acute complications of existing movement disorders that need immediate attention and rapid management which can be life-saving [1, 2]. This chapter deals with the clinical presentation, diagnosis and management of some common movement disorders presenting to the emergency department (ED).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Poston KL, Frucht SJ. Movement disorder emergencies. J Neurol. 2008;255(Suppl 4):2–13.

    Article  Google Scholar 

  2. Frucht SJ. Movement disorder emergencies. Curr Neurol Neurosci Rep. 2005;5:284–93.

    Article  Google Scholar 

  3. Kipps CM, Fung VS, Grattan–Smith P, et al. Movement disorder emergencies. Mov Disord. 2005;20:322–34.

    Article  Google Scholar 

  4. Fernandez HH, Friedman JH. Acute parkinsonism. In: Frucht SJ, Fahn S, editors. Movement disorder emergencies: diagnosis and treatment. Totowa: Humana Press; 2005. p. 9–28.

    Chapter  Google Scholar 

  5. Howard RS, Lees AJ. Encephalitis lethargica: a report of four recent cases. Brain. 1987;110:19–33.

    Article  Google Scholar 

  6. Mirsattari SM, Power C, Nath A. Parkinsonism with HIV infection. Mov Disord. 1998;13:684–9.

    Article  CAS  Google Scholar 

  7. Pradhan S, Pandey N, Shashank S, et al. Parkinsonism due to predominant involvement of substantianigra in Japanese encephalitis. Neurology. 1999;53:1781–6.

    Article  CAS  Google Scholar 

  8. Choi IS. Parkinsonism after carbon monoxide poisoning. Eur Neurol. 2002;48:30–3.

    Article  Google Scholar 

  9. Manji H, Howard RS, Miller DH, et al. Status dystonicus: the syndrome and its management. Brain. 1998;121:243–52.

    Article  Google Scholar 

  10. Fasano A, Ricciardi L, Bentivoglio AR, et al. Status dystonicus: predictors of outcome and progression patterns of underlying disease. Mov Disord. 2012;27:783–8.

    Article  Google Scholar 

  11. Mishra D, Singhal S, Juneja M. Status dystonicus a rare complication of dystonia. Indian Pediatr. 2010;47:883–5.

    Article  Google Scholar 

  12. Svetel M, Sternic N, Pejovic S, Kostic VS. Penicillamine-induced lethal status dystonicus in a patient with Wilson’s disease. Mov Disord. 2001;16:568–9.

    Article  CAS  Google Scholar 

  13. Paliwal VK, Gupta PK, Pradhan S. Gabapentin as a rescue drug in D-penicillamine-induced status dystonicus in patients with Wilson disease. Neurol India. 2010;58:761–3.

    Article  Google Scholar 

  14. Apetauerova D, Schirmer CM, Shils JL, Zani J, Arle JE. Successful bilateral deep brain stimulation of the globuspallidusinternus for persistent status dystonicus and generalized chorea. J Neurosurg. 2010;113:634–8.

    Article  Google Scholar 

  15. Muirhead W, Jalloh I, Vloeberghs M. Status dystonicus resembling the intrathecal baclofen withdrawal syndrome: a case report and review of the literature. J Med Case Rep. 2010;4:294.

    Article  Google Scholar 

  16. Vaamonde J, Narbona J, Weiser R, et al. Dystonic storms: a practical management problem. Clin Neuropharmacol. 1994;17:344–7.

    Article  CAS  Google Scholar 

  17. Nirenberg MJ, Ford B. Dystonic storm. In: Frucht SJ, editor. Movement disorder emergencies: diagnosis and treatment. 2nd ed. New York: Springer/Human Press; 2013. p. 125–35.

    Chapter  Google Scholar 

  18. Mariotti P, Fasano A, Contarino MF, et al. Management of status dystonicus: our experience and review of the literature. Mov Disord. 2007;22:963–8.

    Article  Google Scholar 

  19. Jech R, Bares M, Urgosik D, et al. Deep brain stimulation in acute management of status dystonicus. Mov Disord. 2009;24:2291–2.

    Article  Google Scholar 

  20. Zorzi G, Marras C, Nardocci N, et al. Stimulation of the globuspallidusinternus for childhood-onset dystonia. Mov Disord. 2005;20:1194–200.

    Article  Google Scholar 

  21. Sacks OW, Kohl M. L-dopa and oculogyric crises. Lancet. 1970;296:215–6.

    Article  Google Scholar 

  22. Philbrick KL, Rummans TA. Malignant catatonia. J Neuropsychiatry Clin Neurosci. 1994;6:1–13.

    Article  CAS  Google Scholar 

  23. Fricchione G, Bush G, Fozdar M, et al. Recognition and treatment of the catatonic syndrome. J Intensive Care Med. 1997;12:135–47.

    Article  Google Scholar 

  24. Fricchione G, Mann SC, Caroff SN. Catatonia, lethal catatonia, and neuroleptic malignant syndrome. Psychiatr Ann. 2000;3:347–55.

    Article  Google Scholar 

  25. Dewey RB, Jankovic J. Hemiballism–hemichorea. Arch Neurol. 1989;46:862–7.

    Article  Google Scholar 

  26. Lee B, Hwang S, Chang G. Hemiballismus-hemichorea in older diabetic women: a clinical syndrome with MRI correlation. Neurology. 1999;52:646–8.

    Article  CAS  Google Scholar 

  27. Kurlan R, Como PG, Miller B, et al. The behavioral spectrum of tic disorders: a community based study. Neurology. 2002;59:414–20.

    Article  CAS  Google Scholar 

  28. Jankovic J. Tourette’s syndrome. N Engl J Med. 2001;345:1184–92.

    Article  CAS  Google Scholar 

  29. Scott B, Jankovic J, Donovan D. Botulinum toxin into vocal cord in the treatment of malignant coprolalia associated with Tourette’s syndrome. Mov Disord. 1996;11:431–3.

    Article  CAS  Google Scholar 

  30. Jankovic J. Botulinum toxin in the treatment of dystonic tics. Mov Disord. 1994;9:347–9.

    Article  CAS  Google Scholar 

  31. Isono S, Shiba K, Yamaguchi M, et al. Pathogenesis of laryngeal narrowing in patients with multiple system atrophy. J Physiol. 2001;536:237–49.

    Article  CAS  Google Scholar 

  32. Hughes RG, Gibbin KP, Lowe J. Vocal fold abductor paralysis as a solitary and fatal manifestation of multiple system atrophy. J Laryngol Otol. 1998;112:177–8.

    Article  CAS  Google Scholar 

  33. Caroff SN, Mann SC. Neuroleptic malignant syndrome. Med Clin North Am. 1993;77:185–202.

    Article  CAS  Google Scholar 

  34. Velamoor VR, Norman RM, Caroff SN, et al. Progression of symptoms in neuroleptic malignant syndrome. J Nerv Ment Dis. 1994;182:168–73.

    Article  CAS  Google Scholar 

  35. Keck PE, Pope HG, Cohen BM, et al. Risk factors for neuroleptic malignant syndrome. Arch Gen Psychiatry. 1989;46:914–8.

    Article  Google Scholar 

  36. Mann SC, Caroff SN, Fricchione G, et al. Central dopamine hypoactivity and the pathogenesis of the neuroleptic malignant syndrome. Psychiatr Ann. 2000;30:363–74.

    Article  Google Scholar 

  37. Davis JM, Caroff SN, Mann SC. Treatment of neuroleptic malignant syndrome. Psychiatr Ann. 2000;30:325–31.

    Article  Google Scholar 

  38. Caroff SN, Mann SC, Keck PE Jr. Specific treatment of the neuroleptic malignant syndrome. Biol Psychiatry. 1998;44:378–81.

    Article  CAS  Google Scholar 

  39. Mizuno Y, Takubo H, Mizuta E, et al. Malignant syndrome in Parkinson’s disease: Cconcept and review of the literature. Parkinsonism Relat Disord. 2003;9(Suppl 1):S3–9.

    Article  Google Scholar 

  40. Harada T, Mitsuoka K, Kumagai R, et al. Clinical features of malignant syndrome in Parkinson’s disease and related neurological disorders. Parkinsonism Relat Disord. 2003;9(Suppl 1):S15–23.

    Article  Google Scholar 

  41. Ikebe S, Harada T, Hashimoto T, et al. Prevention and treatment of malignant syndrome in Parkinson’s disease: a consensus statement of the malignant syndrome research group. Parkinsonism Relat Disord. 2003;9(Suppl 1):S47–9.

    Article  Google Scholar 

  42. Mackay FJ, Dunn NR, Mann RD. Antidepressants and the serotonin syndrome in general practice. Br J Gen Pract. 1999;49:871–4.

    CAS  PubMed  PubMed Central  Google Scholar 

  43. Dunkley EJ, Isbister GK, Sibbritt D, et al. The hunter serotonin toxicity criteria: simple and accurate diagnostic decision rules for serotonin toxicity. QJM. 2003;96:635–42.

    Article  CAS  Google Scholar 

  44. Isbister GK, Whyte IM. Serotonin toxicity and malignant hyperthermia: role of 5-HT2 receptors. Br J Anaesth. 2002;88:603–4.

    Article  CAS  Google Scholar 

  45. Radomski JW, Dursun SM, Revely MA, et al. An exploratory approach to the serotonin syndrome; an update of clinical phenomenology and revised diagnostic criteria. Med Hypotheses. 2000;55:218–24.

    Article  CAS  Google Scholar 

  46. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Text Revision. Washington DC: American Psychiatric Association; 2000.

    Google Scholar 

  47. Ayers JL, Dawson KP. Acute dystonic reactions in childhood to drugs. N Z Med J. 1980;92:464–5.

    CAS  PubMed  Google Scholar 

  48. Raja M, Azzoni A. Novel antipsychotics and acute dystonic reactions. Pharmacol Biochem Behav. 2000;67:497–500.

    Article  Google Scholar 

  49. Sachdev PS. Neuroleptic-induced movement disorders: an overview. Psychiatr Clin North Am. 2005;28:255–74.

    Article  Google Scholar 

  50. Keepers GA, Casey DE. Clinical management of acute neuroleptic-induced extrapyramidal syndromes. In: Masserman JH, editor. Current psychiatric therapies. New York: Grune & Stratton; 1986. p. 139–57.

    Google Scholar 

  51. Miller CH, Fleischhacker WW. Managing antipsychotic-induced acute and chronic akathisia. Drug Saf. 2000;22:73–81.

    Article  CAS  Google Scholar 

  52. Hu S, Frucht S. Emergency treatment of movement disorders. Curr Treat Options Neurol. 2007;9:103–14.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Consultant Neurologist, Fortis Hospital, Vasant Kunj, New Delhi, India

    Madhuri Behari

  2. Department of Neurology, Seven Hills Hospital, Mumbai, Maharashtra, India

    Vibhor Pardasani

Authors
  1. Madhuri Behari
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vibhor Pardasani
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Neurology, All India Institute of Medical Sciences, New Delhi, India

    Mamta Bhushan Singh

  2. Department of Neurology, All India Institute of Medical Sciences, New Delhi, India

    Rohit Bhatia

Rights and permissions

Reprints and permissions

Copyright information

© 2019 The Author(s)

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Behari, M., Pardasani, V. (2019). Movement Disorders in the Emergency. In: Singh, M., Bhatia, R. (eds) Emergencies in Neurology . Springer, Singapore. https://doi.org/10.1007/978-981-13-7381-7_6

Download citation

  • DOI: https://doi.org/10.1007/978-981-13-7381-7_6

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-13-7379-4

  • Online ISBN: 978-981-13-7381-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation